Lethal clinical outcome and chemotherapy and immunotherapy resistance in patients with urothelial carcinoma with MDM2 amplification or overexpression
MDM2扩增或过表达的尿路上皮癌患者出现致命的临床结局以及化疗和免疫治疗耐药性
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2024-010964
Jin, Kaifeng; Ding, Yawei; Xu, Jingtong; Liu, Zhaopei; Zeng, Han; Su, Xiaohe; Zhang, Lingkai; Sun, Jiaxing; Wu, Yuzhen; Liu, Hailong; Chang, Yuan; Zhu, Yu; Wang, Zewei; Xu, Le; Zhang, Weijuan; Xu, Jiejie